Fujifilm reveals liver cancer statistics in Thailand, emphasizing on screening for early detection to save lives

Mr. Kosuke Kijima, Asia Pacific & India, Overseas Sales & Marketing Specialist (In Vitro Diagnostics Division – Medical Systems Business Division), FUJIFILM Corporation, underscored the cutting-edge technology employed in a clinical practice guideline from The Japan Society of Hepatology (JSH) saying, “JSH advises combining ultrasound with biomarkers, including Lectin-reactive alpha-fetoprotein (AFP-L3), AFP, and protein induced by vitamin K absence or antagonist-II (PIVKA-II), for HCC surveillance. The JSH clinical practice guideline for HCC 2021 recommends measuring AFP, PIVKA-II, and AFP-L3 fractions as effective tumor markers for HCC diagnosis. AFP-L3, particularly secreted in early tumor stages, aids in detecting previously undetected HCC by ultrasound. This makes AFP-L3 valuable for early HCC detection, prognosis prediction, and treatment…